The company has strategically sold a property for Rs 16.92 Cr.

The proceeds from this sale, along with an additional Rs 0.08 Cr from internal accruals, have been utilized to infuse Rs 17 Cr into its derivatives business.

This capital infusion is intended to strengthen and expand the company's operations in this segment, signaling a focused approach towards optimizing its business portfolio for growth.